Further, since PSMA has been shown to be expressed both in the neovasculature of primary gastric and colorectal tumors as well as in metastases, PSMA-targeting approaches may provide an alternative or an addition to currently available antiangiogenic diagnosis and treatment strategies for the development of new theranostic protocols in these tumor entities [66]. Here, FOLH1 is linked to neoplasm.